Efficacy and Safety of Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000000912
Abstract: BACKGROUND Omalizumab has been proposed as a possible effective treatment of chronic spontaneous urticaria (CSU). STUDY QUESTION We aimed to access the efficacy and safety of omalizumab in the treatment of CSU based on qualified,… read more here.
Keywords: safety omalizumab; score; chronic spontaneous; omalizumab ... See more keywords
Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15303
Abstract: Chronic spontaneous urticaria (CSU) is characterized by the spontaneous development of wheals, itching, and/or angioedema, for ≥6 weeks. In China, non‐sedating H1‐antihistamines (H1AH) are the recommended first‐line treatment, with escalation up to 4× the standard dose… read more here.
Keywords: spontaneous urticaria; safety; safety omalizumab; efficacy safety ... See more keywords
Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2022.851177
Abstract: Objective To evaluate the efficacy and safety of omalizumab in the treatment of severe or uncontrolled allergic diseases in children. Methods We conducted a systematic search of the PubMed, Embase, CENTRAL, and clinicaltrials.gov databases up… read more here.
Keywords: efficacy safety; safety omalizumab; review; allergic ... See more keywords